Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. BDMD
stocks logo

BDMD

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Financial AI Agent
Financial AI Agent

Valuation Metrics

The current forward P/E ratio for Baird Medical Investment Holdings Ltd (BDMD.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Baird Medical Investment Holdings Ltd 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

BDMD News & Events

Events Timeline

(ET)
2025-04-09
08:32:40
Baird Medical expands global presence of microwave ablation technology
select
2025-03-10 (ET)
2025-03-10
08:32:38
Baird Medical receives Indonesian approval for Microwave Ablation technology
select
2024-10-09 (ET)
2024-10-09
08:32:08
Baird Medical lists in U.S. on the Nasdaq Exchange
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
5.0
12-03PRnewswire
Baird Medical Appoints New CEO to Accelerate U.S. Market Expansion
  • Leadership Change: Baird Medical appoints Mark Saxton as CEO of its U.S. subsidiary, leveraging his 25 years of experience in the medical device sector to drive rapid growth in the U.S. market.
  • Market Expansion Strategy: Saxton's successful track record at VNUS Medical, where he doubled annual revenue from $49M to over $100M, is expected to unlock new market opportunities for Baird Medical's Microwave Ablation technology.
  • Innovative Technology Advantage: Baird Medical's Microwave Ablation platform offers significant benefits in minimally invasive care, and Saxton will focus on enhancing patient access while building long-term value for shareholders.
  • Global Market Presence: Baird Medical leads the thyroid microwave ablation device market in China, and Saxton's leadership is anticipated to further propel its commercial expansion across over 20 countries worldwide.
[object Object]
Preview
1.0
10-21PRnewswire
Baird Medical Fosters Advanced Physician Training at International Thyroid Microwave Ablation Workshop in Malaysia

  • Company Announcement: Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) has successfully participated in a Thyroid Microwave Ablation Workshop in Malaysia.

  • Event Details: The workshop took place at the Hospital Canselor Tuanku Muhriz (HCTM) of The National University of Malaysia, highlighting the company's commitment to advancing minimally invasive Microwave Ablation technology.

[object Object]
Preview
7.5
10-01Newsfilter
Baird Medical Enhances Microwave Ablation Training at Top Thyroid Centers in the U.S.

  • Baird Medical's Training Initiatives: Baird Medical Investment Holdings Ltd. has conducted physician training programs at Tulane and Columbia University to enhance the clinical skills of doctors in using Microwave Ablation (MWA) technology for thyroid nodule treatment.

  • Commitment to Clinical Excellence: The company emphasizes its dedication to improving patient outcomes through expert training and partnerships with leading academic institutions, aiming to establish MWA as a preferred treatment for thyroid disease.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Baird Medical Investment Holdings Ltd (BDMD) stock price today?

The current price of BDMD is 1.63 USD — it has increased 8.67 % in the last trading day.

arrow icon

What is Baird Medical Investment Holdings Ltd (BDMD)'s business?

Baird Medical Investment Holdings Ltd is a company mainly engaged in the microwave ablation medical device business. The Company is mainly engaged in the provision of microwave ablation medical device. The medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps.

arrow icon

What is the price predicton of BDMD Stock?

Wall Street analysts forecast BDMD stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BDMD is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Baird Medical Investment Holdings Ltd (BDMD)'s revenue for the last quarter?

Baird Medical Investment Holdings Ltd revenue for the last quarter amounts to -1.02M USD, decreased -70.78 % YoY.

arrow icon

What is Baird Medical Investment Holdings Ltd (BDMD)'s earnings per share (EPS) for the last quarter?

Baird Medical Investment Holdings Ltd. EPS for the last quarter amounts to -780762.00 USD, decreased -43.51 % YoY.

arrow icon

What changes have occurred in the market's expectations for Baird Medical Investment Holdings Ltd (BDMD)'s fundamentals?

The market is revising No Change the revenue expectations for BDMD for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -29.44%.
arrow icon

How many employees does Baird Medical Investment Holdings Ltd (BDMD). have?

Baird Medical Investment Holdings Ltd (BDMD) has 143 emplpoyees as of December 05 2025.

arrow icon

What is Baird Medical Investment Holdings Ltd (BDMD) market cap?

Today BDMD has the market capitalization of 59.97M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free